Publications by authors named "Saranyou Suwanugsorn"
Impact of Procedural Success Definitions on Long-Term Outcomes in Patients With Rheumatic Mitral Stenosis Treated With Percutaneous Balloon Mitral Valvuloplasty: A Multicenter, Retrospective Cohort Study.
J Am Heart Assoc
August 2024
Article Synopsis
- - The study investigated how different success definitions for percutaneous balloon mitral valvuloplasty (PBMV) affect long-term outcomes in patients with severe rheumatic mitral stenosis.
- - Researchers analyzed three success criteria related to mitral valve area (MVA) and mitral regurgitation (MR) and found that achieving any of these definitions was linked to a lower risk of adverse outcomes like mortality and the need for additional heart procedures.
- - All three success definitions were shown to significantly impact patient prognosis, with the most favorable outcomes occurring in patients with an MVA of at least 1.5 cm and controlled MR levels.
Article Synopsis
- Percutaneous balloon mitral valvuloplasty (PBMV) is typically not recommended for patients with mitral stenosis and moderate mitral regurgitation, but some small studies suggest it may be safe and feasible.
- A study at Songklanagarind hospital reviewed 618 patients, finding that those with moderate MR before PBMV had similar procedural success and mid-term outcomes compared to those with less-than-moderate MR.
- The results indicate that PBMV can be an effective and safe treatment option for rheumatic mitral stenosis patients with moderate mitral regurgitation.
We aimed to evaluate the incremental prognostic value after incorporation of the ankle-brachial index (ABI) into the 10-year pool cohort equation (PCE) risk model in patients with multiple risk factors (MRFs). A total of 4332 MRFs patients were divided into 2 groups as ABI ≤.9 or >.
View Article and Find Full Text PDFArticle Synopsis
- The Mayo Cardiac Intensive Care Unit Admission Risk Score (M-CARS) was evaluated for its effectiveness in predicting both in-hospital and post-discharge mortality specifically in Asian patients admitted to the cardiac care unit.
- The study included 1988 patients, with a 5.9% in-hospital mortality rate, showing a significant correlation between higher M-CARS scores and increased mortality risks.
- The findings indicated that M-CARS demonstrated strong predictive ability for in-hospital mortality (C-statistic of 0.840) and reasonable accuracy for one-year post-discharge mortality (C-statistic of 0.727).
Purpose: To validate the modified World Health Organization (WHO) classification in pregnant women with congenital and acquired heart diseases.
Patients And Methods: The database of pregnant women with heart disease, who delivered at Songklanagarind Hospital between January 1995 and December 2016, was retrieved from the Statistical Unit, Department of Obstetrics and Gynecology, along with the Hospital Information System of Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University. Each patient was retrospectively classified according to the modified WHO classification of maternal cardiovascular risk.
Background: NT-proBNP is being used as a biomarker for prognosticating and delineating cardiac dysfunction. The cut-off value for deciding normal versus abnormal levels has always been a point of contention since it depends on the degree of dysfunction as well as other associated conditions often termed non-cardiac factors and parameters. Such association had not been formally presented.
View Article and Find Full Text PDF